These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 6180364)

  • 1. Comparative in vitro enzyme activities of five commercially available pancreatic supplements.
    Shaw DW; Barbezat GO
    N Z Med J; 1982 Jun; 95(710):424-5. PubMed ID: 6180364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability.
    Aloulou A; Puccinelli D; Sarles J; Laugier R; Leblond Y; Carrière F
    Aliment Pharmacol Ther; 2008 Feb; 27(3):283-92. PubMed ID: 17973644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In-vitro analysis of substances used in pancreozymin substitution therapy].
    Malis F; Fric P
    Arzneimittelforschung; 1974 Apr; 24(4):499-504. PubMed ID: 4408063
    [No Abstract]   [Full Text] [Related]  

  • 4. Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relations between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts.
    Graham DY
    N Engl J Med; 1977 Jun; 296(23):1314-7. PubMed ID: 16212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic exocrine insufficiency. IV. The enzyme content of commercial pancreatic supplements.
    Pairent FW; Howard JM
    Arch Surg; 1975 Jun; 110(6):739-41. PubMed ID: 1147772
    [No Abstract]   [Full Text] [Related]  

  • 6. An analysis of pancreatic enzymes used in epidermal separation.
    Omar A; Krebs A
    Arch Dermatol Res (1975); 1975 Sep; 253(2):203-12. PubMed ID: 1238061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro studies of pancreatic enzyme substitution].
    Otte M; Ridder P; Dageförde J
    Dtsch Med Wochenschr; 1987 Sep; 112(39):1498-502. PubMed ID: 2443331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enzymatic activity of different pancreatic supplements: in vitro studies for the determination of the compounds with major therapeutic effect].
    Galván E; Sierra O; Robles-Díaz G; Uscanga L; Campuzano Fernández M
    Rev Gastroenterol Mex; 1985; 50(3):219-23. PubMed ID: 2417301
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of amylase, lipase and trypsin activities in the preparation Pancreas].
    Kakol H
    Acta Pol Pharm; 1970; 27(5):519. PubMed ID: 5501750
    [No Abstract]   [Full Text] [Related]  

  • 11. Change in enzyme content and manufacturer of Viokase.
    Berardi RR; Colvin CL
    Clin Pharm; 1985; 4(4):388. PubMed ID: 4042558
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreatic enzymic activities of commercial pancreatic enzyme preparations incubated in human small intestinal juice.
    Ihse I; Lilja P
    Digestion; 1979; 19(1):48-51. PubMed ID: 456768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of pancreatic proteases II. --Determination of chymotrypsin by succinyl-phenylalanine-p-nitroanilide and its applications].
    Bieth J; Métais P; Warter J
    Ann Biol Clin (Paris); 1968; 26(1):143-58. PubMed ID: 5651931
    [No Abstract]   [Full Text] [Related]  

  • 14. [Enzymatic efficacy of pancreatic substitution preparations. Analysis of tablets].
    Malis F; Fric P
    Vnitr Lek; 1974 Jul; 20(7):658-65. PubMed ID: 4846255
    [No Abstract]   [Full Text] [Related]  

  • 15. Proteolytic inactivation of lipase as a possible cause of the uneven results obtained with enzyme substitution in pancreatic insufficiency.
    Pap A; Varró V
    Hepatogastroenterology; 1984 Feb; 31(1):47-50. PubMed ID: 6199274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of sequential statistical procedures to the study of enzymatic concentrations of human normal pancreatic juice].
    Schmidt B; Cornée J; Delachaume-Salem E
    C R Seances Soc Biol Fil; 1970; 164(8):1813-8. PubMed ID: 4253211
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of two methods to measure amylase, lipase, trypsin, and chymotrypsin activity and the effect of freezing and thawing on enzyme activities in pancreatic juice.
    Gabert VM; Jensen MS
    Pancreas; 1997 Aug; 15(2):183-90. PubMed ID: 9260204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymic activities of commercial preparations of pancreatic enzymes.
    Drummond S; Saunders JH; Leach R; Wormsley KG
    Scott Med J; 1977 Jul; 22(3):221-4. PubMed ID: 887916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of product formulation on in vitro activity of pancreatic enzymes.
    Dressman JB; Shtohryn LV; Diokno D
    Am J Hosp Pharm; 1985 Nov; 42(11):2502-6. PubMed ID: 4073069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.